In a landscape where traditional treatments often fall short, oligonucleotide therapeutics emerge as game-changers offering precise targeting and potentially life-altering outcomes.

The 4th Oligonucleotides for CNS Summit is the only forum wholly dedicated to unique challenges and neuroscience innovation for this modality; delving into the hottest ASO, siRNA, saRNA, and miRNA program updates and latest industry challenges.

This July, Beacon’s RNA Senior Research Analyst, Ioana Panait, joins 50+ senior industry leaders across the space to explore the oligonucleotide therapy development for neurological disorders landscape. Discover the full presentation breakdown here! Make sure to add this pivotal event to your calendar today.